← Back to Manufacturing

Medicinal and Botanical Manufacturing

Industry Overview

Stock Screener

Select filters to narrow down the 110 companies below

110 companies
$0B >$1T

Ratio between share price and earnings per share. A low ratio could indicate undervaluation.

<0 >50

Ratio of dividends in the last 12 months to current share price.

0% 3%

Revenue increase compared to the same quarter one year ago.

0% 30%

Net income increase compared to the same quarter one year ago.

0% 30%

Profitability of the last quarter.

<-30% >30%

A higher ratio indicates a higher risk. The ratio is difficult to compare between industries.

<0 >3

Discounted cash flow valuation vs. current price. Positive = undervalued, negative = overvalued.

<-50% >+100%
Market Cap
Dividends Ratio of dividends in the last 12 months to current share price
P/E Ratio
Revenue Revenue of the last quarter YoY Change
Net income Net income of the last quarter YoY Change
Profit margin Profit margin of the last quarter

Novo Nordisk - ADR

NVO

Novo Nordisk - ADR

NVO
Market Cap $219.88B
Dividends 3.6%
P/E Ratio 11.7
Revenue $96.8B +24.0%
Net Income $48.6B +67.2%
Profit Margin +50.2%
View Stock

GSK Plc - ADR

GSK

GSK Plc - ADR

GSK
Market Cap $105.71B
Dividends 3.4%
P/E Ratio 13.5
Revenue $7.63B +1.5%
Net Income $1.74B +7.0%
Profit Margin +22.8%
View Stock

Verona Pharma Plc - ADR

VRNA

Verona Pharma Plc - ADR

VRNA
Market Cap $72.68B
Dividends 0.0%
P/E Ratio -2155.4
Revenue $103M
Net Income $11.9M -116.8%
Profit Margin +11.6%
View Stock

Bayer AG

BAYZF

Bayer AG

BAYZF
Market Cap $56.12B
Dividends
P/E Ratio
Revenue $13.6B -0.8%
Net Income $2.81B +116.2%
Profit Margin +20.6%
View Stock

Bayer AG - ADR

BAYRY

Bayer AG - ADR

BAYRY
Market Cap $56.12B
Dividends 0.2%
P/E Ratio -22.9
Revenue $13.6B -0.8%
Net Income $2.81B +116.2%
Profit Margin +20.6%
View Stock

Takeda Pharmaceutical Co - ADR

TAK

Takeda Pharmaceutical Co - ADR

TAK
Market Cap $52.33B
Dividends 3.7%
P/E Ratio 43.9
Revenue $1.11T +5.8%
Net Income -$24.8B -76.0%
Profit Margin -2.2%
View Stock

Royalty Pharma plc - Ordinary Shares - Class A

RPRX

Royalty Pharma plc - Ordinary Shares - Class A

RPRX
Market Cap $24.27B
Dividends 1.6%
P/E Ratio 22.9
Revenue $631M +11.0%
Net Income $295M +23.8%
Profit Margin +46.8%
View Stock

Astellas Pharma Inc. - ADR

ALPMY

Astellas Pharma Inc. - ADR

ALPMY
Market Cap $23.74B
Dividends 3.6%
P/E Ratio 13.2
Revenue $647B +41.0%
Net Income $58B -22.6%
Profit Margin +9.0%
View Stock

Sino Biopharmaceutical Ltd. - ADR

SBHMY

Sino Biopharmaceutical Ltd. - ADR

SBHMY
Market Cap $11.27B
Dividends 1.9%
P/E Ratio 34.4
Revenue $7.13B +9.8%
Net Income -$523M -316.6%
Profit Margin -7.3%
View Stock

Dr. Reddy`s Laboratories Ltd. - ADR

RDY

Dr. Reddy`s Laboratories Ltd. - ADR

RDY
Market Cap $10.98B
Dividends 0.6%
P/E Ratio 24.2
Revenue $76.3B -10.3%
Net Income $2.24B -86.0%
Profit Margin +2.9%
View Stock

Indivior PLC

IZQVF

Indivior PLC

IZQVF
Market Cap $5.05B
Dividends 0.0%
P/E Ratio 20.1
Revenue $317M +19.2%
Net Income $89M +89.4%
Profit Margin +28.1%
View Stock

Indivior Plc - ADR

INVVY

Indivior Plc - ADR

INVVY
Market Cap $5.05B
Dividends 0.0%
P/E Ratio 20.1
Revenue $317M +19.2%
Net Income $89M +89.4%
Profit Margin +28.1%
View Stock

Indivior Plc

INDV

Indivior Plc

INDV
Market Cap $5.05B
Dividends 0.0%
P/E Ratio 20.1
Revenue $317M +19.2%
Net Income $89M +89.4%
Profit Margin +28.1%
View Stock

Edgewise Therapeutics Inc

EWTX

Edgewise Therapeutics Inc

EWTX
Market Cap $4.89B
Dividends 0.0%
P/E Ratio -27.4
Revenue $0.00
Net Income -$49M +20.1%
Profit Margin
Employees 19
View Stock

Terns Pharmaceuticals Inc

TERN

Terns Pharmaceuticals Inc

TERN
Market Cap $4.77B
Dividends 0.0%
P/E Ratio -51.4
Revenue $0.00
Net Income -$23.6M +8.1%
Profit Margin
Employees 30
View Stock

Aspen Pharmacare Holdings Ltd - ADR

APNHY

Aspen Pharmacare Holdings Ltd - ADR

APNHY
Market Cap $4B
Dividends 1.4%
P/E Ratio -33.6
Revenue $16.3B -25.9%
Net Income $1.4B -41.3%
Profit Margin +8.6%
View Stock

Organon & Co.

OGN

Organon & Co.

OGN
Market Cap $3.55B
Dividends 0.6%
P/E Ratio 14.2
Revenue $1.46B -3.5%
Net Income $146M +67.8%
Profit Margin +10.0%
View Stock

Regencell Bioscience Holdings Ltd

RGC

Regencell Bioscience Holdings Ltd

RGC
Market Cap $2.91B
Dividends 0.0%
P/E Ratio -414.1
Revenue $0.00
Net Income -$5.32M +186.9%
Profit Margin
View Stock

Hypera S.A. - ADR

HYPMY

Hypera S.A. - ADR

HYPMY
Market Cap $2.88B
Dividends 5.2%
P/E Ratio 7.9
Revenue $1.98B +83.2%
Net Income $341M -343.6%
Profit Margin +17.2%
View Stock

Trevi Therapeutics Inc

TRVI

Trevi Therapeutics Inc

TRVI
Market Cap $2.53B
Dividends 0.0%
P/E Ratio -55.4
Revenue $0.00
Net Income -$13.2M +27.6%
Profit Margin
View Stock